🔎 Trials Near Me

Utama › Kanser Darah › North Carolina › Durham

Kajian klinikal Kanser Darah di Durham, NC

16 kajian untuk Kanser Darah sedang mencari peserta di lokasi dalam dan sekitar Durham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Mengambil pesertaKajian pemerhatian
  • Duke University Medical Center, Durham
Semua umur · Semua jantina · Dikemas kini 5 Okt 2026 · NCT04242095

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Mengambil pesertaFasa 3
  • Duke Cancer Center ( Site 0028), Durham
  • University of North Carolina at Chapel Hill ( Site 0040), Chapel Hill · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT03486873

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Durham VA Medical Center, Durham
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Mengambil pesertaFasa 3
  • Quetzal Site 27, Chapel Hill · 10 mi jauh
Umur 18 hingga 71 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07504458

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Mengambil pesertaFasa 1/2
  • UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mi jauh
Umur 12 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT04588922

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Mengambil pesertaFasa 3
  • Duke University Medical Center, Durham
  • University of North Carolina, Chapel Hill, Chapel Hill · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07007312

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Mengambil peserta
  • Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi jauh
Umur 60 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT06296368

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Mengambil pesertaFasa 2
  • Lineberger Cancer, Chapel Hill · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06665100

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

Mengambil peserta
  • 2400 Pratt Street, Durham
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jul 2026 · NCT06532773

Implementation of an Oral Chemotherapy Adherence Intervention

Mengambil peserta
  • UNC Chapel Hill, Chapel Hill · 10 mi jauh
Umur 21 ke atas · Semua jantina · Dikemas kini 8 Jul 2026 · NCT06989489

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Mengambil pesertaKajian pemerhatian
  • Duke University Medical Center, Durham
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauh
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Mengambil pesertaFasa 1
  • University of North Carolina, Chapel Hill · 10 mi jauh
Umur 13 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT04771572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Mengambil pesertaFasa 1/2
  • Duke University Medical Center, Duke Cancer Center, Durham
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT03328078

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Mengambil pesertaFasa 1
  • Duke Blood Cancer Center, Durham
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Mac 2026 · NCT05735184

HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT

Mengambil pesertaFasa awal 1
  • Duke University Health System, Durham
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jan 2026 · NCT06731504

Kajian Kanser Darah di bandar lain

Kajian lain di Durham

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.